Nuvo Research Inc  

(Public, TSE:NRI)   Watch this stock  
Find more results for NRI
3.28
-0.18 (-5.20%)
Aug 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 3.28 - 3.50
52 week 1.35 - 5.73
Open 3.46
Vol / Avg. 19,643.00/23,527.00
Mkt cap 33.59M
P/E     -
Div/yield     -
EPS -1.12
Shares 10.24M
Beta 0.29
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -99.49% -56.37%
Operating margin -104.68% -56.67%
EBITD margin - -11.76%
Return on average assets -50.57% -41.42%
Return on average equity -89.16% -61.65%
Employees 79 -
CDP Score - -

Address

Unit 10, 7560 Airport Road
MISSISSAUGA, ON L4T 4H4
Canada
+1-905-6736980 (Phone)
+1-905-6731842 (Fax)

Website links

Description

Nuvo Research Inc. is a specialty pharmaceutical company. The Company is engaged in building a portfolio of products for the treatment of pain through internal research and development (R&D), in-licensing and acquisition. The Company�s product portfolio includes Pennsaid, Pliaglis and Synera. Through its subsidiary Nuvo Research AG, the Company is also developing the compound WF10, for the treatment of immune related diseases. The Company�s Pain Group located in West Chester, Pennsylvania is focused on the development and commercialization of topically delivered pain products, including Pennsaid. On May 12, 2011, the Company obtained control of ZARS Pharma, Inc. On December 13, 2011, the Company acquired remaining 40% interest in Nuvo Research AG.

Officers and directors

Daniel H. Chicoine Chairman of the Board, Co-Chief Executive Officer
John C. London President, Co-Chief Executive Officer, Director
Stephen L. Lemieux Chief Financial Officer, Vice President
Henrich R. K. Guntermann M.D. President of Europe and Immunology Group, Director
Bradley S. Galer M.D. President of Pain Group
Age: 52
Katina Loucaides Vice President, General Counsel, Secretary
David A. Copeland Lead Independent Director
Anthony E. Dobranowski Independent Director
Jacques Messier Independent Director
Theodore H. Stanley M.D. Independent Director
Age: 73